Table I.

Lower-risk food allergy procedures and scenarios for which virtual health could be considered during and after COVID-19, especially for patients living in areas with limited access to these procedures (eg, rural settings)

1. Virtually supervised early allergen introduction in infants

(a) Infants with mild-to-moderate eczema

(b) Infants with an older sibling with peanut allergy

(c) Infants with a first-degree relative with an atopic condition (eczema, food allergy, asthma, or allergic rhinitis)

(d) Hesitancy in infants with no eczema or current food allergy

(e) Infants who have negative or weakly positive screening skin prick and/or sIgE testing without a history of ingestion of the food

2. Virtually supervised oral food challenges

(a) Any patient with an unconvincing history of food allergy in combination with negative or weakly positive skin prick and/or sIgE testing

(b) Food sensitization tested as a panel and/or the absence of a history suggesting symptomatic ingestion, including testing done for evaluation of atopic dermatitis

(c) Reintroduction of foods in children who had food allergy testing for eczema (where the food has been avoided for more than 2 y starting in infancy)

(d) Reintroduction of foods avoided due to eosinophilic esophagitis

3. Virtually supervised oral immunotherapy

(a) Peanut OIT for lower-risk preschoolers

(b) OIT counseling/education before initiation of OIT

(c) OIT follow-up to assess adherence

OFC, Oral food challenge; OIT, oral immunotherapy; sIgE, specific IgE.